The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Amyloid-β-Induced Pathological Behaviors Are Suppressed by Ginkgo biloba Extract EGb 761 and Ginkgolides in Transgenic Caenorhabditis elegans
Open accessAbstract
Amyloid-β (Aβ) toxicity has been postulated to initiate synaptic loss and subsequent neuronal degeneration seen in Alzheimer's disease (AD). We previously demonstrated that the standardized Ginkgo biloba extract EGb 761, commonly used to enhance memory and by AD patients for dementia, inhibits Aβ-induced apoptosis in neuroblastoma cells. In this study, we use EGb 761 and its single constituents to associate Aβ species with Aβ-induced pathological behaviors in a model organism,Caenorhabditis elegans.We report that EGb 761 and one of its components, ginkgolide A, alleviates Aβ-induced pathological behaviors, including paralysis, and reduces chemotaxis behavior and 5-HT hypersensitivity in a transgenic C. elegans. We also show that EGb 761 inhibits Aβ oligomerization and Aβ deposits in the worms. Moreover, reducing oxidative stress is not the mechanism by which EGb 761 and ginkgolide A suppress Aβ-induced paralysis because the antioxidant l-ascorbic acid reduced intracellular levels of hydrogen peroxide to the same extent as EGb 761, but was not nearly as effective in suppressing paralysis in the transgenic C. elegans. These findings suggest that (1) EGb 761 suppresses Aβ-related pathological behaviors, (2) the protection against Aβ toxicity by EGb 761 is mediated primarily by modulating Aβ oligomeric species, and (3) ginkgolide A has therapeutic potential for prevention and treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 2×
“A leading theory is that A oligomers are responsible for initiation of synaptic dysfunction, an early event that leads to neurodegeneration observed in AD (Walsh and Selkoe, 2004; Roselli et al., 2005; Lesne et al., 2006; Oddo et al., 2006).”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationThe Nematode Caenorhabditis elegans
Wood, W. B. (1988) · Cold Spring Harbor Laboratory eBooks · Cited by 3,037
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways
Bitan, G., Kirkitadze, M. D., Lomakin, A., Vollers, S. S., Benedek, G. B., & Teplow, D. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222681699 · Cited by 1,287
Odorant-selective genes and neurons mediate olfaction in C. elegans
Bargmann, C. I., Hartwieg, E., & Horvitz, H. R. (1993) · Cell · doi:10.1016/0092-8674(93)80053-h · Cited by 1,225
Sawin, E. R., Ranganathan, R., & Horvitz, H. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)81199-x · Cited by 1,076
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061
Self-citationA Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966
Opposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans
Zhang, Y., Lu, H., & Bargmann, C. I. (2005) · Nature · doi:10.1038/nature04216 · Cited by 809
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
Link, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9368 · Cited by 687
Self-citationGinkgo biloba for cognitive impairment and dementia
Birks, J., & Grimley Evans, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120.pub3 · Cited by 581
Serotonin and Octopamine in the Nematode Caenorhabditis elegans
Horvitz, H. R., Chalfie, M., Trent, C., Sulston, J. E., & Evans, P. D. (1982) · Science · doi:10.1126/science.6805073 · Cited by 580
Self-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
Self-citationOligomers on the Brain: the Emerging Role of Soluble Protein Aggregates in Neurodegeneration.
Walsh, D., & Selkoe, D. (2004) · Protein & Peptide Letters · doi:10.2174/0929866043407174 · Cited by 428
Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761
Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A., Curry, K. J., Buford, J. P., Khan, I., Netzer, W. J., Xu, H., & Butko, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425199 · Cited by 398
Self-citationTemporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease
Oddo, S., Caccamo, A., Tran, L., Lambert, M. P., Glabe, C. G., Klein, W. L., & LaFerla, F. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507892200 · Cited by 379
Self-citationBastianetto, S., Ramassamy, C., Doré, S., Christen, Y., Poirier, J., & Quirion, R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00069.x · Cited by 379
Self-citationDrake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371
Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodies
Lambert, M. P., Viola, K. L., Chromy, B. A., Chang, L., Morgan, T. E., Yu, J., Venton, D. L., Krafft, G. A., Finch, C. E., & Klein, W. L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00592.x · Cited by 349
Self-citationIn silico study of amyloid β-protein folding and oligomerization
Urbanc, B., Cruz, L., Yun, S., Buldyrev, S. V., Bitan, G., Teplow, D. B., & Stanley, H. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408153101 · Cited by 332
Ono, K., & Yamada, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03707.x · Cited by 320
Schafer, W. R., & Kenyon, C. J. (1995) · Nature · doi:10.1038/375073a0 · Cited by 316
Monoclonal antibodies that target pathological assemblies of Aβ
Lambert, M. P., Velasco, P. T., Chang, L., Viola, K. L., Fernandez, S., Lacor, P. N., Khuon, D., Gong, Y., Bigio, E. H., Shaw, P., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04157.x · Cited by 314
Self-citationGene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model
Link, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00224-5 · Cited by 301
Self-citationWalsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., Agnaf, O. E., Hartley, D. M., & Selkoe, D. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4391-04.2005 · Cited by 286
Roselli, F., Tirard, M., Lu, J., Hutzler, P., Lamberti, P., Livrea, P., Morabito, M., & Almeida, O. F. X. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3034-05.2005 · Cited by 277
Smith, P. F., Maclennan, K., & Darlington, C. L. (1996) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(96)01379-7 · Cited by 261
MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans
Ranganathan, R., Cannon, S. C., & Horvitz, H. R. (2000) · Nature · doi:10.1038/35044083 · Cited by 242
Smith, J. V., & Luo, Y. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5404 · Cited by 242
Self-citationMazza, M., Capuano, A., Bria, P., & Mazza, S. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01409.x · Cited by 237
The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba
Watanabe, C. M. H., Wolffram, S., Ader, P., Rimbach, G., Packer, L., Maguire, J. J., Schultz, P. G., & Gohil, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111126298 · Cited by 234
Stackman, R. W., Eckenstein, F., Frei, B., Kulhanek, D., Nowlin, J., & Quinn, J. F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00399-6 · Cited by 230
Brignull, H. R., Moore, F. E., Tang, S. J., & Morimoto, R. I. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0990-06.2006 · Cited by 211
Kienlen-Campard, P., Miolet, S., Tasiaux, B., & Octave, J.-N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200887200 · Cited by 187
Ranganathan, R., Sawin, E. R., Trent, C., & Horvitz, H. R. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-05871.2001 · Cited by 185
Yao, Z.-X., Drieu, K., & Papadopoulos, V. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03131-0 · Cited by 181
Serotonin mediates food-odor associative learning in the nematode Caenorhabditis elegans
Nuttley, W. M., Atkinson-Leadbeater, K. P., & van der Kooy, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192101699 · Cited by 181
DeKosky, S. T., Fitzpatrick, A., Ives, D. G., Saxton, J., Williamson, J., Lopez, O. L., Burke, G., Fried, L., Kuller, L. H., Robbins, J., et al. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.02.007 · Cited by 176
Behavioral plasticity in C. elegans: Paradigms, circuits, genes
Hobert, O. (2003) · Journal of Neurobiology · doi:10.1002/neu.10168 · Cited by 173
Mix, J. A., & Crews, W. D. (2002) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.412 · Cited by 168
Le Bars, P. L., Kieser, M., & Itil, K. Z. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017242 · Cited by 164
Ginkgo Biloba for cognitive impairment and dementia
Birks, J., & Evans, J. G. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003120 · Cited by 163
Link, C. D., Johnson, C. J., Fonte, V. G., Paupard, M., Hall, D. H., Styren, S. D., Mathis, C. A., & Klunk, W. E. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00237-2 · Cited by 157
Self-citationTerpene trilactones from Gingko biloba: From ancient times to the 21st century
Nakanishi, K. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.014 · Cited by 143
Strayer, A. L., Wu, Z., Christen, Y., Link, C. D., & Luo, Y. (2003) · The FASEB Journal · doi:10.1096/fj.03-0376fje · Cited by 131
Self-citationNakanishi, K. (1967) · Pure and Applied Chemistry · doi:10.1351/pac196714010089 · Cited by 118
Terpene Trilactones from Ginkgo biloba Are Antagonists of Cortical Glycine and GABAA Receptors
Ivic, L., Sands, T. T., Fishkin, N. E., Nakanishi, K., Kriegstein, A. R., & Strømgaard, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304034200 · Cited by 114
Invertebrate models of Alzheimer's disease
Link, C. D. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00105.x · Cited by 99
Self-citationTransgenic C. elegans as a Model in Alzheimers Research
Wu, Y., & Luo, Y. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772768 · Cited by 95
Self-citationMaezawa, I., Hong, H., Wu, H., Battina, S. K., Rana, S., Iwamoto, T., Radke, G. A., Pettersson, E., Martin, G. M., Hua, D. H., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03862.x · Cited by 88
Link, C. D., Fonte, V. G., Hiester, B. G., Yerg, J., Ferguson, J., Csontos, S., Silverman, M. A., & Stein, G. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505581200 · Cited by 85
Self-citationAndrieu, S., Guyonnet, S., Amouyal-Barkate, K., Nourhashémi, F., Reynish, E. L., Ousset, P., Albarède, J. L., Vellas, B. J., & Grandjean, H. (2003) · The Journals of Gerontology Series A · doi:10.1093/gerona/58.4.m372 · Cited by 84
Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease
Luo, Y. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3407 · Cited by 76
Self-citationGenes Affecting Sensitivity to Serotonin in Caenorhabditis elegans
Schafer, W. R., Sanchez, B. M., & Kenyon, C. J. (1996) · Genetics · doi:10.1093/genetics/143.3.1219 · Cited by 69
What is Ginkgo biloba extract EGb 761? An overview--from molecular biology to clinical medicine.
Christen, Y., & Maixent, J. M. (2002) · PubMed · Cited by 67
Self-citationZandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47
Magnitude of Effect and Special Approach to Ginkgo biloba Extract EGb 761® in Cognitive Disorders
Bars, P. L. L. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40458 · Cited by 43
DeFeudis, F. V. (2002) · Drug Development Research · doi:10.1002/ddr.10151 · Cited by 38
Interactions between Caenorhabditis elegans Individuals during Chemotactic Response
Matsuura, T., Sato, T., & Shingai, R. (2005) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.22.1095 · Cited by 31
Kondratskaya, E., Pankratov, Y. V., Lalo, U., Chatterjee, S. S., & Krishtal, O. A. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00126-8 · Cited by 24
Gutierrez-Zepeda, A., & Luo, Y. (2004) · Frontiers in bioscience · doi:10.2741/1485 · Cited by 14
Self-citationThe Role of Alzheimer Aβ Peptides in Ion Transport Across Cell Membranes
Ingram, V. M. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_17 · Cited by 6
Cited by
Pandey, U. B., & Nichols, C. D. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003293 · Cited by 1,136
Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology
Leung, M. C. K., Williams, P. L., Benedetto, A., Au, C., Helmcke, K. J., Aschner, M., & Meyer, J. N. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn121 · Cited by 1,027
Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., et al. (2016) · Scientific Reports · doi:10.1038/srep34477 · Cited by 463
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442
Self-citationSingh, S. K., Srivastav, S., Castellani, R. J., Plascencia-Villa, G., & Perry, G. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00767-8 · Cited by 401
Metadata
- Authors
- Wu, Y., Wu, Z., Butko, P., Christen, Y., Lambert, M. P., Klein, W. L., Link, C. D., & Luo, Y.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-12-13
- Volume
- 26
- Issue
- 50
- Pages
- 13102-13113
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2031231661
- Cited by
- 406
- References
- 69
- FWCI
- 8.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.